Bifogade filer
Kurs
-6,25%
Kurs
-6,25%
Open
2,12
High
2,30
Low
1,85
Close
2,10
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Kalender
Est. tid* | ||
2026-06-12 | N/A | Årsstämma |
2026-02-12 | 08:40 | Bokslutskommuniké 2025 |
2025-11-13 | 08:40 | Kvartalsrapport 2025-Q3 |
2025-08-14 | 08:40 | Kvartalsrapport 2025-Q2 |
2025-06-13 | N/A | X-dag ordinarie utdelning INDCT 0.00 NOK |
2025-06-12 | N/A | Årsstämma |
2025-05-19 | 08:40 | Kvartalsrapport 2025-Q1 |
2025-02-13 | - | Bokslutskommuniké 2024 |
2024-11-14 | - | Kvartalsrapport 2024-Q3 |
2024-08-15 | - | Kvartalsrapport 2024-Q2 |
2024-06-17 | - | X-dag ordinarie utdelning INDCT 0.00 NOK |
2024-06-14 | - | Årsstämma |
2024-05-16 | - | Kvartalsrapport 2024-Q1 |
2024-02-15 | - | Bokslutskommuniké 2023 |
2023-11-15 | - | Kvartalsrapport 2023-Q3 |
2023-08-17 | - | Kvartalsrapport 2023-Q2 |
2023-06-21 | - | Årsstämma |
2023-06-15 | - | X-dag ordinarie utdelning INDCT 0.00 NOK |
2023-05-16 | - | Kvartalsrapport 2023-Q1 |
2023-02-15 | - | Bokslutskommuniké 2022 |
2022-11-15 | - | Kvartalsrapport 2022-Q3 |
2022-08-17 | - | Kvartalsrapport 2022-Q2 |
2022-05-12 | - | Kvartalsrapport 2022-Q1 |
2022-05-02 | - | X-dag ordinarie utdelning INDCT 0.00 NOK |
2022-02-15 | - | Bokslutskommuniké 2021 |
2021-11-01 | - | Kvartalsrapport 2021-Q3 |
2021-09-27 | - | Extra Bolagsstämma 2021 |
2021-08-16 | - | Kvartalsrapport 2021-Q2 |
2021-06-28 | - | Årsstämma |
2021-05-04 | - | X-dag ordinarie utdelning INDCT 0.00 NOK |
2021-05-03 | - | Kvartalsrapport 2021-Q1 |
2021-02-16 | - | Bokslutskommuniké 2020 |
2020-10-30 | - | Kvartalsrapport 2020-Q3 |
2020-08-14 | - | Kvartalsrapport 2020-Q2 |
2020-06-29 | - | Årsstämma |
2020-04-30 | - | Kvartalsrapport 2020-Q1 |
2020-02-04 | - | X-dag ordinarie utdelning INDCT 0.00 NOK |
2020-02-03 | - | Bokslutskommuniké 2019 |
2019-10-31 | - | Kvartalsrapport 2019-Q3 |
2019-08-15 | - | Kvartalsrapport 2019-Q2 |
2019-06-05 | - | X-dag ordinarie utdelning INDCT 0.00 NOK |
2019-04-30 | - | Kvartalsrapport 2019-Q1 |
2018-12-20 | - | Extra Bolagsstämma 2018 |
2018-04-13 | - | X-dag ordinarie utdelning INDCT 0.00 NOK |
2018-02-16 | - | Bokslutskommuniké 2017 |
2017-11-15 | - | Kvartalsrapport 2017-Q3 |
2017-08-15 | - | Kvartalsrapport 2017-Q2 |
2017-05-16 | - | Kvartalsrapport 2017-Q1 |
2017-02-17 | - | Bokslutskommuniké 2016 |
2016-09-30 | - | Kvartalsrapport 2016-Q2 |
2016-05-31 | - | Bokslutskommuniké 2015 |
2016-04-18 | - | Extra Bolagsstämma 2016 |
Beskrivning
Land | Norge |
---|---|
Lista | Euronext Growth Oslo |
Sektor | Informationsteknik |
Industri | Programvara |
2024-08-15 07:00:00
The Interim report for Q2 2024 for Induct AS has been approved by the Board of
Directors.
o Total revenues of NOK 5,1 million in Q2 2024 compared to NOK 6,2 million in Q2
2023.
o Platform revenues of NOK 4,2 million in Q2 2024 compared to NOK 5,2 million in
Q2 2023.
o Gross margin on platform revenues at 95,1%.
o EBITDA up by 117,6% from NOK 1,7 million in Q2 2023 to NOK 3,7 million in Q2
2024.
For further information, please contact: Synnøve Jacobsen, Chief Executive
Officer +47 99 41 54 47 sj@induct.net
About Induct
Induct AS was established in 2007 and was a first mover in the development of
software as a service (SaaS) for managing innovation efforts in, and between,
organizations. Our software has enabled more than 350 organizations worldwide to
release the potential that lies in identifying new and good ideas through
innovation engagement and realizing the benefits of turning good ideas into new
ways of thinking, acting, organizing, and working. In 2020, Induct took a new
step on its journey as a knowledge empowerment provider. We launched a new
digital platform - induct.net - where work and collaboration are taken to a new
level for organizations and individuals alike. By removing unnecessary and
unhelpful barriers to collaboration, the platform is a unique facilitator of
knowledge development and management, sharing and empowerment within
organizations, in collaborative networks, and in ecosystems. Induct has
offerings in three main segments: 1) Patient data and patient management, 2)
Grants and grant management and 3) Innovation and innovation management. Want to
learn more? Visit us at induct.net